Machiraju et al. analyzed tumor samples from 90 patients with advanced cutaneous melanoma and found that increased filtration with TIM-3+ T cells in pretreatment metastases was associated with significantly shorter PFS under anti–PD-1 therapy (p = 0.019) [66]. The gene discussed is HAVCR2; the disease is neoplasm.